Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma (Q37248755)

19 August 2017

Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma (English)

1 reference

19 August 2017

0 references

Yeon Seok Seo

1

1 reference

19 August 2017

Jin Nam Kim

2

1 reference

19 August 2017

Bora Keum

3

1 reference

19 August 2017

Sanghoon Park

4

1 reference

19 August 2017

Yong Dae Kwon

5

1 reference

19 August 2017

Yong Sik Kim

6

1 reference

19 August 2017

Yoon Tae Jeen

7

1 reference

19 August 2017

Hoon Jai Chun

8

1 reference

19 August 2017

Chul Yong Kim

9

1 reference

19 August 2017

Chang Duck Kim

10

1 reference

19 August 2017

Ho Sang Ryu

11

1 reference

19 August 2017

Soon Ho Um

12

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

World Journal of Gastroenterology

19 August 2017

1 reference

19 August 2017

14

1 reference

19 August 2017

2394-2400

1 reference

19 August 2017

15

1 reference

Management of hepatocellular carcinoma

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Post-radiation survival time in hepatocellular carcinoma based on predictors for CT-determined, transarterial embolization and various other parameters

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Combined interventional therapies of hepatocellular carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Dose-response relationship in local radiotherapy for hepatocellular carcinoma.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Nonsurgical treatment of hepatocellular carcinoma in cirrhotic patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Hepatic toxicity resulting from cancer treatment.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Treatment of primary liver cancer: response to regional chemotherapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Hepatic resection in 120 patients with hepatocellular carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Local radiotherapy for patients with unresectable hepatocellular carcinoma.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705096

Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma

3 September 2018

1 reference

12 December 2020

Radiotherapy for hepatocellular carcinoma

1 reference

12 December 2020

Dose volume histogram analysis of liver radiation tolerance

1 reference

12 December 2020

A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge

1 reference

12 December 2020

Primary hepatic malignancy: surgical management and determinants of survival

1 reference

12 December 2020

Hepatic resection for hepatocellular carcinoma

1 reference

12 December 2020

Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model

1 reference

12 December 2020

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump

1 reference

12 December 2020

Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma

1 reference

12 December 2020

Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy

1 reference

12 December 2020

Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients

1 reference

12 December 2020

Powerful radiotherapy for hepatocellular carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.14.2394

1 reference

19 August 2017

1 reference

19 August 2017

1 reference